Finance

Lists
Why is SIGHT down 3,17%?
Dive Deeper
SIGHT:EPA
Gensight Biologics SA
0,073 €
-3,17%
(-0,0024) 1D
21 ოქტ, 17:35:16 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SIGHT...
Open
0,08 €
High
0,08 €
Low
0,07 €
Mkt. cap
17,12 მლნ.
Avg. vol.
1,80 მლნ.
Volume
0,00
52-wk high
0,24 €
52-wk low
0,07 €
EPS
-0,08 €
Shares outstanding
246,22 მლნ.
No. of employees
18
Open
0,08 €
High
0,08 €
Low
0,07 €
Mkt. cap
17,12 მლნ.
Avg. vol.
1,80 მლნ.
Volume
0,00
52-wk high
0,24 €
52-wk low
0,07 €
EPS
-0,08 €
Shares outstanding
246,22 მლნ.
No. of employees
18
News stories
From web sources and news partners
MarketBeat
MarketBeat
·
48 წუთის წინ
Nuveen NASDAQ 100 Dynamic Overwrite Fund (NASDAQ:QQQX) Shares Up 1.4% - Should You Buy?
MarketBeat
MarketBeat
·
48 წუთის წინ
BuzzFeed (NASDAQ:BZFD) Stock Price Up 2% - What's Next?
CNBC
CNBC
·
13 საათის წინ
Why the stock market’s fragile calm faces a major test starting Friday
Investor's Business Daily
Investor's Business Daily
·
2 საათის წინ
Futures Fall; Meta, Tesla Lead Big Earnings Late
About Gensight Biologics SA
CEO-
Employees18
Founded2012
Headquartersპარიზი, ილ-დე-ფრანსი, საფრანგეთი
Sector-
Websitegensight-biologics.com
Last report
8 ივლ. 2026
Fiscal period
Q2 2026
- / -
Revenue / Est. (EUR)
-428,00 ათ. / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
302,00 ათ.
302,00 ათ.
-428,00 ათ.
-428,00 ათ.
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,08 მლნ.
1,08 მლნ.
2,34 მლნ.
2,34 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,36 მლნ.
1,36 მლნ.
1,50 მლნ.
1,50 მლნ.
Operating expense
2,43 მლნ.
2,43 მლნ.
3,84 მლნ.
3,84 მლნ.
Total operating expenses
2,43 მლნ.
2,43 მლნ.
3,84 მლნ.
3,84 მლნ.
Operating income
-2,13 მლნ.
-2,13 მლნ.
-4,27 მლნ.
-4,27 მლნ.
Other non operating income
436,00 ათ.
436,00 ათ.
-285,50 ათ.
-285,50 ათ.
EBT including unusual items
-2,53 მლნ.
-2,53 მლნ.
-5,14 მლნ.
-5,14 მლნ.
EBT excluding unusual items
-2,53 მლნ.
-2,53 მლნ.
-5,14 მლნ.
-5,14 მლნ.
Income tax expense
2,00 ათ.
2,00 ათ.
500,00
500,00
Effective tax rate
-0,08%
-0,08%
-0,01%
-0,01%
Other operating expenses
-
-
-
-
Net income
-2,53 მლნ.
-2,53 მლნ.
-5,14 მლნ.
-5,14 მლნ.
Net profit margin
-839,24%
-839,24%
1 199,88%
1 199,88%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-784,50 ათ.
-784,50 ათ.
-578,00 ათ.
-578,00 ათ.
Net interest expenses
-784,50 ათ.
-784,50 ათ.
-578,00 ათ.
-578,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,09 მლნ.
-2,09 მლნ.
-4,24 მლნ.
-4,24 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები